| Patient | Winston Churchill |
|---|---|
| Date of birth | 1947-11-30 |
| Identifiers | MRN HR-ET001-SYN; SSN (made up) 000-01-8846 |
| Document date | 2026-11-01 |
| Author | Beatrice Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care transition visit eight days after a minor ischemic stroke. Concerns: Wants to return to full work and to give a major speech within about three months; Fears another stroke, but does not want to give up cigars or his drinking habits entirely. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily for 21 days with clopidogrel | One tablet by mouth daily | Oral route | 2026-06-23 to 2026-07-14 | completed | S |
| Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital) | One tablet by mouth daily | Oral route | 2026-06-23 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-06-23 | active | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-06-26 to 2026-07-01 | completed | S |
| Amlodipine 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-07-01 to 2026-07-29 | completed | S |
| Lisinopril 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-07-15 | active | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-07-29 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| MRI of the brain in the hospital: acute 12 mm lacunar infarct in the right internal capsule and corona radiata; chronic small-vessel white-matter changes in both hemispheres; no hemorrhage | 2026-06-23 to 2026-06-23 | completed | S |
| CT angiography of the head and neck in the hospital: no carotid, vertebral, or intracranial stenosis or occlusion | 2026-06-23 to 2026-06-23 | completed | S |
| Transthoracic echocardiography with bubble study in the hospital: normal left ventricular size and function, mild left ventricular hypertrophy, normal left atrium, no thrombus, no shunt | 2026-06-24 to 2026-06-24 | completed | S |
| 12-lead electrocardiogram: sinus rhythm 72/min, left ventricular hypertrophy by voltage, no atrial fibrillation | 2026-07-01 to 2026-07-01 | completed | S |
| 30-day ambulatory ECG monitoring: sinus rhythm throughout, occasional atrial ectopic beats, no atrial fibrillation or flutter | 2026-07-15 to 2026-08-14 | completed | S |
| Outpatient physical and occupational therapy for left-sided weakness and hand dexterity, twice weekly, completed | 2026-07-06 to 2026-09-25 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2025-10-14 | High-dose influenza vaccine, 2025-2026 season | completed | S |
| 2022-11-07 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 2024-09-23 | Respiratory syncytial virus vaccine, single dose | completed | S |
| 2019-05-20 | Recombinant zoster vaccine, two-dose series completed | completed | S |
| 2018-03-12 | Tdap vaccine | completed | S |
| 2026-10-28 | High-dose influenza vaccine, 2026-2027 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| December 1941 | Chest pain at the White House after straining to open a window; read at the time as a heart attack, but no heart disease was found and the episode was probably musculoskeletal (disputed) | R (CLM-0002) |
| December 1943 | Critical pneumonia in Tunis, treated with sulfonamides | D (CLM-0003) |
| August 1949 | First stroke, a less serious attack at Cap d'Ail described as spasm of a small artery | D (CLM-0004) |
| 1950 to 1952 | Further cerebrovascular episodes, including transient ischemic attacks, from 1950 to 1952 | D (CLM-0004) |
| 23 June 1953 | Stroke at a dinner at 10 Downing Street: left hemiparesis with a drooping mouth and slurred speech, worst on the third day; kept secret at the time | D (CLM-0005, CLM-0006) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died in 1895 at 45 after a progressive illness with speech and hearing problems, dizziness, and numbness; cause disputed and not established in the cited source | 45 | R (CLM-0013) |
| Concern | Status | Evidence |
|---|---|---|
| Wants to return to full work and to give a major speech within about three months | active | S |
| Fears another stroke, but does not want to give up cigars or his drinking habits entirely | active | S |
Most recent measures: Sodium [Moles/volume] in Serum or Plasma 137 on 2026-07-29; Potassium [Moles/volume] in Serum or Plasma 4.6 on 2026-07-29; Creatinine [Mass/volume] in Serum or Plasma 1.12 on 2026-07-29; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 67 on 2026-07-29; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-07-29; Hemoglobin [Mass/volume] in Blood 14.2 on 2026-07-01; Platelets [#/volume] in Blood by Automated count 245 on 2026-07-01; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-07-01; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28 on 2026-08-19; Total score [NIH Stroke Scale] 1 on 2026-07-29; Total score [MoCA] 27 on 2026-10-28; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 2026-10-28; Total score [AUDIT-C] 5 on 2026-10-28; Cholesterol [Mass/volume] in Serum or Plasma 128 on 2026-08-19; Cholesterol in HDL [Mass/volume] in Serum or Plasma 48 on 2026-08-19; Triglyceride [Mass/volume] in Serum or Plasma 110 on 2026-08-19; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 58 on 2026-08-19; Modified rankin scale 1 on 2026-10-07 [S]
Strengths and supports: Supports: married and lives with his spouse; adult children; a large, devoted staff [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Mild left hemiparesis and dysarthria after a right-hemisphere lacunar infarct eight days before intake; synthetic modern episode linked to the documented 1953 stroke | active | confirmed | I69.354 | S — Synthetic modern diagnosis; the 1953 stroke remains D in the history. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic diagnosis supported by the documented raised blood pressure after the 1953 stroke. |
| Nicotine dependence, cigars, six to eight a day | active | confirmed | F17.290 | S — Synthetic coded diagnosis echoing the documented lifelong cigar smoking. |
| Orthostatic hypotension after antihypertensive intensification in hot weather, resolved after reducing amlodipine | resolved | confirmed | I95.1 | S — Synthetic medication-related intercurrent problem at an unscheduled visit; it does not echo a documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-01 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-07-01 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-07-01 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-07-01 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 79 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-01 | Glucose [Mass/volume] in Serum or Plasma | 97 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-07-01 | Hemoglobin [Mass/volume] in Blood | 14.2 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-07-01 | Platelets [#/volume] in Blood by Automated count | 245 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-07-01 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 2026-07-01 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 | U/L | 7-56 U/L | Normal | S |
| 2026-07-01 | Total score [NIH Stroke Scale] | 2 | {score} | S | ||
| 2026-07-01 | Total score [MoCA] | 26 | {score} | S | ||
| 2026-07-01 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-07-01 | Total score [AUDIT-C] | 8 | {score} | S | ||
| 2026-07-15 | Total score [NIH Stroke Scale] | 1 | {score} | S | ||
| 2026-08-19 | Cholesterol [Mass/volume] in Serum or Plasma | 128 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-08-19 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 48 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-08-19 | Triglyceride [Mass/volume] in Serum or Plasma | 110 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-08-19 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 58 | mg/dL | <=99 mg/dL | Normal | S |
| 2026-08-19 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 | U/L | 7-56 U/L | Normal | S |
| 2026-08-19 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 2026-08-19 | Total score [AUDIT-C] | 5 | {score} | S | ||
| 2026-10-07 | Modified rankin scale | 1 | {score} | S | ||
| 2026-10-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-07-29 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-07-29 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-07-29 | Creatinine [Mass/volume] in Serum or Plasma | 1.12 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-07-29 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 67 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-29 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-07-29 | Total score [NIH Stroke Scale] | 1 | {score} | S | ||
| 2026-10-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-10-28 | Total score [MoCA] | 27 | {score} | S | ||
| 2026-10-28 | Total score [AUDIT-C] | 5 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-01 | Body height | 168 | cm | S |
| 2026-07-01 | Body weight | 80 | kg | S |
| 2026-07-01 | Body mass index (BMI) [Ratio] | 28.3 | kg/m2 | S |
| 2026-07-01 | Systolic blood pressure | 152 | mm[Hg] | S |
| 2026-07-01 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-07-01 | Heart rate | 72 | /min | S |
| 2026-07-01 | Respiratory rate | 16 | /min | S |
| 2026-07-01 | Body temperature | 36.7 | Cel | S |
| 2026-07-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 2026-07-15 | Body height | 168 | cm | S |
| 2026-07-15 | Body weight | 79.6 | kg | S |
| 2026-07-15 | Body mass index (BMI) [Ratio] | 28.2 | kg/m2 | S |
| 2026-07-15 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2026-07-15 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-07-15 | Heart rate | 70 | /min | S |
| 2026-07-15 | Respiratory rate | 16 | /min | S |
| 2026-07-15 | Body temperature | 36.6 | Cel | S |
| 2026-07-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 2026-08-19 | Body height | 168 | cm | S |
| 2026-08-19 | Body weight | 79 | kg | S |
| 2026-08-19 | Body mass index (BMI) [Ratio] | 28 | kg/m2 | S |
| 2026-08-19 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-08-19 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-08-19 | Heart rate | 70 | /min | S |
| 2026-08-19 | Respiratory rate | 16 | /min | S |
| 2026-08-19 | Body temperature | 36.7 | Cel | S |
| 2026-08-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-10-07 | Body height | 168 | cm | S |
| 2026-10-07 | Body weight | 78.6 | kg | S |
| 2026-10-07 | Body mass index (BMI) [Ratio] | 27.8 | kg/m2 | S |
| 2026-10-07 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-10-07 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-07 | Heart rate | 68 | /min | S |
| 2026-10-07 | Respiratory rate | 16 | /min | S |
| 2026-10-07 | Body temperature | 36.6 | Cel | S |
| 2026-10-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-07-29 | Body height | 168 | cm | S |
| 2026-07-29 | Body weight | 78.8 | kg | S |
| 2026-07-29 | Body mass index (BMI) [Ratio] | 27.9 | kg/m2 | S |
| 2026-07-29 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-07-29 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-07-29 | Heart rate | 76 | /min | S |
| 2026-07-29 | Respiratory rate | 16 | /min | S |
| 2026-07-29 | Body temperature | 36.8 | Cel | S |
| 2026-07-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-10-28 | Body height | 168 | cm | S |
| 2026-10-28 | Body weight | 78.4 | kg | S |
| 2026-10-28 | Body mass index (BMI) [Ratio] | 27.8 | kg/m2 | S |
| 2026-10-28 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-10-28 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-10-28 | Heart rate | 68 | /min | S |
| 2026-10-28 | Respiratory rate | 16 | /min | S |
| 2026-10-28 | Body temperature | 36.6 | Cel | S |
| 2026-10-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-07-01 | Primary care transition visit eight days after a minor ischemic stroke | finished | S |
| 2026-07-15 | Two-week stroke review at the end of dual antiplatelet therapy, and neurology consultation | finished | S |
| 2026-08-19 | Eight-week stroke and blood pressure review with lipid panel and rhythm-monitor results | finished | S |
| 2026-10-07 | Three-month stroke review before returning to public speaking | finished | S |
| 2026-07-29 | Same-day sick visit for lightheadedness on standing | finished | S |
| 2026-10-28 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Aspirin with clopidogrel for 21 days after the minor stroke, then clopidogrel 75 mg alone | completed | GL-STROKE-2021, GL-CMID-2026 | S |
| Atorvastatin 80 mg with a lipid panel 4 to 12 weeks after starting, aiming for LDL cholesterol below 70 mg/dL | completed | GL-STROKE-2021, GL-CMID-2026 | S |
| Lower blood pressure below 130/80 with amlodipine and lisinopril, checking standing blood pressure at each visit and a basic metabolic panel 1 to 2 weeks after starting lisinopril | completed | GL-STROKE-2021, GL-HTN-2025, GL-CMID-2026 | S |
| Neurology consultation to confirm the stroke mechanism, set the antiplatelet plan after the 21-day course, decide on prolonged cardiac rhythm monitoring, and advise on return to work and public speaking | completed | GL-STROKE-2021, GL-ARRH-2024 | S |
| Outpatient physical and occupational therapy for left-sided weakness, with fall-risk review at every visit | completed | GL-PCAS-2021, GL-CMID-2026 | S |
| PHQ-9 at the first visit and at each review while symptoms persist, MoCA again within the first year, and attention to post-stroke tearfulness | completed | GL-PCAS-2021, GL-CMID-2026 | S |
| Brief interventions at every visit for unhealthy alcohol use (AUDIT-C, no more than two drinks a day) and cigar smoking, with nicotine replacement offered | completed | GL-STROKE-2021, GL-USPSTF-ALCOHOL-2018, GL-TOBACCO-2021 | S |
| Yearly influenza vaccine and current COVID-19 vaccine | completed | GL-STROKE-2021, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Lower blood pressure below 130/80 mmHg without orthostatic symptoms by the eight-week review | 2026-08-19 | completed | Blood pressure 128/76 mmHg on amlodipine 5 mg and lisinopril 5 mg; no orthostatic fall | S |
| Lower LDL cholesterol below 70 mg/dL by the eight-week review | 2026-08-19 | completed | LDL cholesterol 58 mg/dL on atorvastatin 80 mg | S |
| Return to full work and public speaking by about three months after the stroke | 2026-10-07 | completed | Back at full work; modified Rankin Scale 1 | S |
| Keep to no more than two drinks on any day | 2026-10-07 | active | AUDIT-C from 8 to 5; no longer drinking six or more on one occasion, but still above two drinks on some days | S |
| Cut down to three cigars a day as a step toward stopping | 2026-10-07 | completed | Three cigars a day; not ready to stop | S |